BIO to Testify at House Hearing on User Fee Reauthorization

Mar 5 2002
WASHINGTON, D.C. (March 5, 2002) - Mary Pendergast, executive vice president for government affairs at Elan Pharmaceuticals, will testify tomorrow on behalf of the Biotechnology Industry...


Mar 4 2002
(WASHINGTON, DC) - March 4, 2002 - After a four-month delay, the Centers for Medicare and Medicaid Services (CMS) issued a corrected regulation on pass-through payments for innovative medications...

BIO Appears in Fortune Special Section on Biotechnology

Mar 4 2002

BIO Names Genentech’s Susan Desmond-Hellmann to Board

Feb 28 2002
Washington, D.C. (February 28, 2002)-The board of directors of the Biotechnology Industry Organization (BIO) voted unanimously to add Susan Desmond-Hellmann, M.D., M.P.H., to their ranks. Desmond...

BIO Names Amgen’s Dennis Fenton to Board

Feb 28 2002
Washington, D.C. (February 28, 2002)-The Biotechnology Industry Organization (BIO) board of directors has by unanimous vote named Dennis M. Fenton, Ph.D., to their ranks. Fenton is executive vice...

John Davidson, Tom Von Essen Featured Speakers for BIO 2002

Feb 27 2002
Washington, D.C. (February 27, 2002)-Two heroes, one from Canada and one from the U.S. were named today as headlining speakers for the BIO 2002 International Convention and Exhibition. John...

MEDIA ADVISORY --- BIO CEO & Investor Conference 2002: Highlight of Events for Friday, February 22, 2002

Feb 22 2002
WHERE: Waldorf=Astoria Hotel, New York 10:40 a.m. – 12: 00 p.m.Investor Session 13Jade Room Enhancing the Therapeutic Profile of Anti-cancer...

MEDIA ADVISORY --- BIO CEO & Investor Conference 2002: Highlights for Thursday, February 21, 2002

Feb 21 2002
Where: Waldorf=Astoria Hotel, New York

9:30 - 10:30 a.m.Press ConferenceHerbert Hoover Room Accenture Press Conference - Accenture...

Two Companies Awarded 2002 Helix Award for Corporate Excellence

Feb 21 2002
New York– (February 21, 2002) – CV Therapeutics and Isis Pharmaceuticals were presented with the seventh Annual Helix Award at the Biotechnology Industry Organization’s CEO &...

BIO Statement on NAS Report on Transgenic Plants

Feb 21 2002
(Dr. Michael J. Phillips, executive director for food and agriculture of the Biotechnology Industry Organization (BIO) issued the following statement in response to today’s National...